Literature DB >> 10541310

Alpha-mannosidosis in the guinea pig: a new animal model for lysosomal storage disorders.

A C Crawley1, M Z Jones, L E Bonning, J W Finnie, J J Hopwood.   

Abstract

Alpha-mannosidosis is a lysosomal storage disorder resulting from deficient activity of lysosomal alpha-mannosidase. It has been described previously in humans, cattle, and cats, and is characterized in all of these species principally by neuronal storage leading to progressive mental deterioration. Two guinea pigs with stunted growth, progressive mental dullness, behavioral abnormalities, and abnormal posture and gait, showed a deficiency of acidic alpha-mannosidase activity in leukocytes, plasma, fibroblasts, and whole liver extracts. Fractionation of liver demonstrated a deficiency of lysosomal (acidic) alpha-mannosidase activity. Thin layer chromatography of urine and tissue extracts confirmed the diagnosis by demonstrating a pattern of excreted and stored oligosaccharides almost identical to that of urine from a human alpha-mannosidosis patient. Widespread neuronal vacuolation was observed throughout the CNS, including the cerebral cortex, hippocampus, thalamus, cerebellum, midbrain, pons, medulla, and the dorsal and ventral horns of the spinal cord. Lysosomal vacuolation also occurred in many other visceral tissues and was particularly severe in pancreas, thyroid, epididymis, and peripheral ganglion. Axonal spheroids were observed in some brain regions, but gliosis and demyelination were not observed. Ultrastructurally, most vacuoles in both the CNS and visceral tissues were lucent or contained fine fibrillar or flocculent material. Rare large neurons in the cerebral cortex contained fine membranous structures. Skeletal abnormalities were very mild. Alpha-mannosidosis in the guinea pig closely resembles the human disease and will provide a convenient model for investigation of new therapeutic strategies for neuronal storage diseases, such as enzyme replacement and gene replacement therapies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541310     DOI: 10.1203/00006450-199911000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Characterization of a human core-specific lysosomal {alpha}1,6-mannosidase involved in N-glycan catabolism.

Authors:  Chaeho Park; Lu Meng; Leslie H Stanton; Robert E Collins; Steven W Mast; Xiaobing Yi; Heather Strachan; Kelley W Moremen
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis.

Authors:  C H Vite; S Magnitsky; D Aleman; P O'Donnell; K Cullen; W Ding; S Pickup; J H Wolfe; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

3.  Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.

Authors:  Markus Damme; Stijn Stroobants; Steven U Walkley; Renate Lüllmann-Rauch; Rudi D'Hooge; Jens Fogh; Paul Saftig; Torben Lübke; Judith Blanz
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

Review 4.  A review of gene therapy in canine and feline models of lysosomal storage disorders.

Authors:  Allison M Bradbury; Brittney L Gurda; Margret L Casal; Katherine P Ponder; Charles H Vite; Mark E Haskins
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-11       Impact factor: 5.032

5.  Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.

Authors:  L Borgwardt; C I Dali; J Fogh; J E Månsson; K J Olsen; H C Beck; K G Nielsen; L H Nielsen; S O E Olsen; H M F Riise Stensland; O Nilssen; F Wibrand; A M Thuesen; T Pearl; U Haugsted; P Saftig; J Blanz; S A Jones; A Tylki-Szymanska; N Guffon-Fouiloux; M Beck; A M Lund
Journal:  J Inherit Metab Dis       Date:  2013-03-14       Impact factor: 4.982

6.  Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.

Authors:  Markus Damme; Willy Morelle; Bernhard Schmidt; Claes Andersson; Jens Fogh; Jean-Claude Michalski; Torben Lübke
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

7.  Functional analysis of an alpha-1,2-mannosidase from Magnaporthe oryzae.

Authors:  Jie Zhou; Cheng-zeng Lin; Xiang-zi Zheng; Xiong-jie Lin; Wei-jian Sang; Shi-hua Wang; Zong-hua Wang; Daniel Ebbole; Guo-dong Lu
Journal:  Curr Genet       Date:  2009-07-21       Impact factor: 3.886

8.  A multi-species comparative structural bioinformatics analysis of inherited mutations in alpha-D-mannosidase reveals strong genotype-phenotype correlation.

Authors:  Javed Mohammed Khan; Shoba Ranganathan
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

Review 9.  Alpha-Mannosidosis: Therapeutic Strategies.

Authors:  Maria Rachele Ceccarini; Michela Codini; Carmela Conte; Federica Patria; Samuela Cataldi; Matteo Bertelli; Elisabetta Albi; Tommaso Beccari
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.